Jan 10 (Reuters) - Elon Musk said on Saturday that social media platform X will open to the public its new algorithm, including all code for organic and advertising post recommendations, in seven days ...

The Johns Hopkins University Data Science and AI Institute welcomes applications for its Postdoctoral Fellowship program, seeking disciplinarily diverse scholars to advance foundational methods of ...

Oracle and other firms are taking out loans to build data centers that they will rent to AI companies. Investors are starting to wonder if that bet will pay off. Stocks in some major companies ...

Some crypto leaders met on Wednesday with key lawmakers as the U.S. Senate is about to take some time off from the negotiations over a crypto market structure bill — the industry's most important ...

The U.S. Senate Banking Committee will not have any markup hearings on market structure legislation defining how federal regulators can oversee the industry until next year, punting on a hoped-for ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Spotify Co-President, CPO, and CTO Gustav Söderström shared a new blog post which details the arrival of the Prompted Playlists feature, which is now under testing. This specific feature deploys an ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...